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Original Article
Frequency and clinical spectrum of rare inherited coagulopathies - A tricenter study
Safoorah Khalid, Fareena Bilwani, Salman Naseem Adil, Mohammad Khurshid 
Department of Pathology and Microbiology, Aga Khan University Hospital, Karachi. 
Abstract
Objective: To determine the frequency of rare inherited coagulopathies at three centers of haematology in
Karachi and to study the clinical spectrum and laboratory data of these coagulopathies.
Methods: This was a descriptive study conducted from September 2003 to December 2004 on subjects from
Aga Khan University Hospital, Husaini Blood Bank and Fatimid Blood Transfusion Centre. All the subjects with
bleeding tendency without any acquired causes of bleeding were selected for further investigation, and were
asked relevant questions as present in the questionnaire. Screening tests including platelet count, PT, APTT and
bleeding time were performed on all patients and subsequently, specific tests including factor assay, clot solubility
test, platelet aggregation and vWFAg were performed.
Results: In total, 1100 patients were evaluated for bleeding tendency at the three centers and 65 patients were
diagnosed to have inherited coagulopathy other than haemophilia A and B. Out of these 65 patients, 33 (50.7%)
were males and 32 (49.2%) were females. Rare inherited coagulopathies that were found in our population
included deficiency of factor VII {n =21 (32.3%)}, factor X {n =17 (26.1%)}, factor XIII {n=14 (21.5%)}, factor V {n
=9 (13.8%)}, fibrinogen {n =2 (3%)}, prothrombin {n=1 (1.5%)} and factor XII {n=1 (1.5%)}.
Conclusion: Inherited coagulopathies other than haemophilia A and B were noted in the study population (JPMA
58:441;2008).
Introduction
Bleeding tendencies caused by inherited
deficiencies of one of the coagulation factors is a rare
phenomenon distributed worldwide. The study of these
disorders has significantly advanced the understanding of
the pathophysiology of blood coagulation mechanisms.1
The most common and best documented of these inherited
disorders are haemophilia A and B, due to mutation in the
factor VIIIc gene and the factor IX gene respectively.2
Mutations have also been identified in deficiency of
factors I, II, V, VII, X, XI, XII and XIII. These rare
disorders are inherited as autosomal recessive traits with
prevalence in the general population varying between 1:
500,000 and 1: 2000,000.3
These disorders are generally less severe than the
haemophilias caused by factor VIII or IX deficiency. The
only exceptions are factor X and XIII deficiencies,
characterized by early onset of life threatening symptoms
such as umbilical cord and central nervous system
bleeding. Bleeding after circumcision is often the
revealing symptom in coagulation factor deficiencies. 
Results of studies using various immunologic
techniques demonstrate that the absence of coagulant
activity in the plasma of patients with these disorders may
result from either deficient biosynthesis of a requisite
protein or defective biosynthesis, leading to the production
of normal amounts of functionally inactive or functionally
abnormal analogues.2
Most of these factor deficiencies are characterized
by prolonged prothrombin time and/ or activated partial
thromboplastin time except for factor XIII which is
characterized by normal initial screening tests. Factor
assay is required for the confirmation of diagnosis.
The study was conducted to define the occurrence
of these disorders in our population so that these patients
are not missed and are managed properly.
Patients and Methods
A descriptive study was conducted from September
2003 to December 2004 at three haematology centers in
Karachi- The Aga Khan University Hospital, Husaini
Blood Bank and Transfusion Center; and Fatimid Blood
Transfusion Center. All the subjects with bleeding
tendency of all ages and both gender were selected for
further investigation. Prior to asking questions and
drawing blood for various tests, patients were informed
about the project in detail and an informed consent was
taken.
During the study period, a total of 1100 patients
were evaluated for bleeding disorder at the three centers.
Patients included in the study were asked relevant
questions as present in the questionnaire.
Detailed history of bleeding tendency was taken
and any history of bleeding at the time of birth including
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bleeding from the umbilical cord and circumcision bleed
was asked, History of consanguineous marriage of parents,
and significant history of bleeding tendency in parents,
siblings, cousins or other family members was inquired
and menstrual and obstetrical history was also noted.
Patients with a positive history were subsequently
investigated. Tests that were performed on blood samples
included, platelet count (Coulter STKS), prothrombin time
(Dade Behring Inc Newark, DE, USA), activated partial
thromboplastin time (Dade Behring Inc, Newark, DE,
USA) and mixing studies4 using normal plasma, adsorbed
plasma and aged serum were performed.
(Aged normal human serum- contains factors II, VII, IX,
X, XI, XII)
(Adsorbed normal human plasma- contains factors I, V,
VIII, XI, XII)
If the prolongation is due to deficiency of a clotting
factor, the PT or APTT should return to normal within a
few seconds.
The other tests done were, Bleeding time (Ivy's
method), Factor assay (II, V, VII, X, XI, XII) Dade
Behring Inc, Newark, DE, USA, Fibrinogen assay (Dade
Behring Inc, Newark, DE, USA), Clot solubility test for
factor XIII, Platelet aggregation studies and Enzyme
linked immunosorbent assay for von Willebrand factor
antigen.
Screening tests including platelet count,
prothrombin time (PT), activated partial thromboplastin
time (APTT) and bleeding time were performed on all
patients and subsequently, specific tests including factor
assay, clot solubility test, platelet aggregation and vWFAg
were performed as required.
Patients suffering from inherited coagulopathies
other than Haemophilia A and B i.e. fibrinogen deficiency,
prothrombin deficiency, deficiency of factors V, VII, X,
XI, XII and XIII were included. Patients with acquired
coagulopathies including vitamin K deficiency, presence
of inhibitors and liver disease were excluded. Patients with
platelet function disorders were also excluded.
Results
Of the 1100 subjects, 65 were diagnosed to have
some rare inherited coagulopathy other than Haemophilia
A and B. Among these, 33 (50.7%) were males and 32
(49.2%) were females. Mean age was 6.3 ± 8.73 years
(range 1-54 years). The most common presenting
complaints were gum bleeding, epistaxis and bruising
after minor trauma. Soft tissue bleeding was the presenting
complaint in 2 (3%) patients whereas haemarthrosis was
found in 1 (1.5%) patient only. Bleeding from the
umbilical cord was found in 52 (80%) patients and
significant circumcision bleed in 4 (6.1%). History of
consanguineous marriage of parents was observed in 22
(33.8%) patients.
Rare inherited coagulopathies that were found in
our population included deficiency of fibrinogen,
prothrombin; factors V, VII, X, XII and XIII. 
The most common rare inherited coagulopathy that
was identified in our population was factor VII deficiency.
Twenty-one patients (32.3%) were diagnosed to be factor
VII deficient of whom eight were males (38%) and
thirteen females (61%). This group of patients had a mean
age of 10.3 ± 12.93 years (range 1-54 years). Majority of
the patients {n =18 (85%)} had history of epistaxis and
gum bleeding off and on since birth. One patient presented
at the age of 54 years when she had significant
haemorrhage while undergoing hysterectomy. Eleven
patients (52%) had history of bleeding from the umbilical
cord. Family history of consanguinity was seen in ten
patients (47%). There was isolated prolonged PT in all
patients and mixing studies revealed correction of PT with
normal plasma and aged serum.
Factor X deficiency was seen in seventeen patients
(26.1%) and out of these; eleven were males (68%) and six
females (32%). Mean age was 3.94 ± 3.74 years (range 1-
14 years). Majority of the patients (94.1%) presented with
history of bruising and gum bleeding since birth, except
for one 14 years old female who presented with complaints
of menorrhagia. Significant birth history including
bleeding from the umbilical cord was seen in nearly all
patients. Only one patient had a family history of
consanguinity. Laboratory investigations revealed
prolongation of both PT and APTT; correction done with
normal plasma and aged serum.
There were fourteen patients (21.5%) with factor
XIII deficiency- eight were males (57%) and six were
females (42%). Mean age was calculated to be 8.28 ± 6.08
years (range 1-18 years). All patients (100%) had history
of prolonged bleeding from the umbilical cord at birth.
However, the commonest presenting complaint was
bruising after minor trauma (90%). Family history was
significant in six patients (42%). Upon investigation, all
patients had normal PT and APTT. Subsequently, clot
solubility test was done in all patients (100%) and all of
them were found to be factor XIII deficient. Quantitative
factor XIII assay was not done since it is not available at
these three centers.
Factor V deficiency was found in nine patients
(13.8%). Two were females (22%) and seven were males
(77%). Mean age at presentation was 8.44 ± 6.63 years
(range 2-22 years). Patients presented with complaints of
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epistaxis and gum bleeding (100%). Haemarthrosis was
seen in one patient. All patients (100%) gave history of
prolonged bleeding from the umbilical cord and four male
patients (44%) had a significant history of circumcision
bleed. There was history of consanguineous marriage of
parents in six patients (66%). Siblings of two patients had
factor V deficiency. When investigated, all of these
patients had prolonged PT and APTT. On mixing studies,
correction was observed with normal and adsorbed
plasma. Factor assay was performed and all patients had
low factor V levels.
Fibrinogen deficiency was seen in two patients
(3%). Both of them presented at an early age with a mean
age of 2 ± 1.4 years (range 1-3 years). Both had history of
hematomas off and on after minor falls.  One patient had
prolonged bleeding from the umbilical cord at birth. Initial
screening tests including PT and APTT were both
prolonged. Mixing studies were performed and correction
was achieved with normal and adsorbed plasma. Plasma
fibrinogen levels were performed and were detected to be
low.
There was only one (1.5%) male patient with factor
XII deficiency who was diagnosed incidentally when pre-
surgical assessment was done before tonsillectomy. Age of
this patient was 8 years. Both PT and APTT were
prolonged and were corrected with normal and adsorbed
plasma and aged serum. Factor XII levels were then
performed and were found to be reduced.
Prothrombin deficiency was found in one patient
(1.5%) who was a 4 years old male. However, clinical
details were not available.
Factor XI deficiency was not discovered in any
patient in this study.
Discussion
The inherited disorders of coagulation are a
fascinating group of diseases that have provided important
insights into the structure and function of their respective
deficient protein(s). These disorders have many and varied
effects on patients and families at all stages of life.  
This study was conducted to determine the
frequency and clinical spectrum of rare inherited
coagulopathies other than Haemophilia A and B. Inherited
coagulopathies that were found in our population, in
descending order of frequency, were deficiency of factors
VII, X, XIII, fibrinogen, prothrombin and factor XII.
Deficiency of fibrinogen, prothrombin and factor XII were
extremely rare. 
These disorders are also reported in other
populations as well. Karimi M et al5 did a comprehensive
survey concerning demographics in the Southern Iranian
population with haemophilia and allied disorders. The
total number of patients with coagulation disorders was
367. Haemophilia A was found in 271, 39 had
Haemophilia B and 24 had vWD. The rare coagulation
disorders (n=33) included eleven patients with factor X
deficiency; ten with factor VII; six with factor XIII; two
with afibrinogenemia; two with factor XI; one with
combined factor V and VIII; and one with combined factor
VII, VIII and IX deficiency. 
Data obtained from the most recent adjournments
(1996) of the registries of inherited bleeding disorders kept
in Iran, Italy and United Kingdom is summarized in Table6
and it is also compared with the present study.
A North American registry for rare bleeding
disorders7 (factor II, VII, X, V, XIII and fibrinogen
deficiencies) was established to gather information about
disease prevalence, genotyping frequency, diagnostic
events, clinical manifestations and prophylaxis strategies.
Questionnaires were sent to 225 haemophilia centers in
USA and Canada. Among 26% of responding centers, 294
individuals were diagnosed with one of the rare bleeding
Table. Number of patients and relative frequency of inherited coagulation disorders in iran, italy and united kingdom (excluding vwd)6 and also
comparison with present study.
Defect Iran Italy United  Kingdom Present Study
Fibrinogen
Prothrombin
Factor V
Factor VII
FactorV+VIII
FactorVIII (Haemophilia A)
FactorIX (Haemophilia B)
Factor X
Factor XI
Factor XIII
70 (1.5%)
15 (0.3%)
70 (1.5%)
300(6.6%)
80 (1.7%)
3000 (65.4%)
900 (19.6%)
60 (1.3%)
20 (0.4%)
80 (1.7%)
10 (0.2%)
7 (0.2%)
21 (0.5%)
58 (1.3%)
29 (0.7%)
3428 (80%)
626 (15%)
16 (0.4%)
60 (1.3%)
31 (0.7%)
11 (0.2%)
1 (0.02%)
28 (0.6%)
62 (1.3%)
18 (0.3%)
3554 (76.8%)
762 (16.1%)
25 (0.5%)
150 (3.3%)
26 (0.5%)
2 (3%)
1 (1.5%)
9 (13.8%)
21 (32.3%)
-
-
-
17 (26.1%)
-
14 (21.5%)
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disorders included in the survey. The most common
coagulopathy was factor VII deficiency. Factor X and
factor XII caused the most severe bleeding manifestations.
There is very limited published local data on rare inherited
coagulopathies. In a combined study conducted at Aga
Khan University Hospital and Fatimid Foundation8 from
1985 to 1992, nine patients were diagnosed to have factor
XIII deficiency on the basis of clot solubility test. A high
incidence of consanguinity was observed in this study. 
Comparing the results of our study with similar
studies conducted worldwide, the frequency of these
inherited disorders is variable. In populations where
consanguineous marriages are frequent, as those from
Muslim countries including our population, recessive
coagulation disorders are more frequent representing a
significant clinical and social problem. 
The total number of patients with rare inherited
coagulation disorders studied by us is limited, although
there are a large number of patients who remain
undiagnosed since the general practitioners do not refer all
patients with suspected bleeding disorders. There is a need
of large scale studies in all parts of our country to
determine the actual burden of these disorders.
Conclusion
Inherited coagulopathies other than Haemophilia A
and B were found in our study population. However, a high
index of clinical suspicion is required to diagnose these
patients. Majority of the patients remain undiagnosed due
to the lack of appropriate diagnostic facilities in all parts of
our country. More prospective studies are required to
define the occurrence of these disorders.
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Reducing the rate of Primary Caesarean Sections - an Audit
Lumaan Sheikh, Sara Tehseen, Saqib Ali Gowani, Hadi Bhurgri, J.H. Rizvi, S. Kagazwala
Department of Obstetrics and Gynecology, the Aga Khan University, Karachi.
Abstract
Objective: To evaluate how the implementation of universally acceptable standards affects rates for primary
caesarean sections, without compromising maternal or foetal safety. 
Methods: A complete audit cycle of all the primary caesarean sections performed in the maternity unit of Aga
Khan University was conducted from1st January to 31st March during years 2003 and 2004. New labour
management guidelines were implemented after the first audit (appendix). The rates of caesarean section,
induction of labour, failed induction, and maternal and foetal outcomes were compared before and after the
implementation of the guidelines.
Results: Primary emergency caesarean section rate decreased from 16% to 12%. A reduction in primary
caesarean sections was noted in the induced cases. Practice of checking cord blood for foetal pH and
maintaining partograms improved markedly. There were no significant adverse maternal and perinatal outcomes. 
Conclusion: Implementation of standard labour management strategies can reduce primary caesarean section
rate without compromising maternal and foetal safety (JPMA 58:444;2008).
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